Literature DB >> 3236355

Prenatal diagnosis of beta thalassaemia by oligonucleotide analysis in Mediterranean populations.

M C Rosatelli1, T Tuveri, M T Scalas, A Di Tucci, G B Leoni, M Furbetta, G Monni, A Cao.   

Abstract

We have used four oligonucleotide probes and two restriction enzymes to detect the beta thalassaemia mutation in a group of 61 couples of Italian descent who were prospective parents. We have been able to define the beta thalassaemia mutation in both parents in 47 couples and in only one parent in 12 couples. Prenatal diagnosis was accomplished successfully either by amniocyte (two) or trophoblast (26) DNA analysis in 28 couples in which the pregnancy was in progress. These results indicate that direct identification of the mutation by oligonucleotide or restriction endonuclease analysis is a practical and useful method for prenatal diagnosis of beta thalassaemia in childless couples.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3236355      PMCID: PMC1051581          DOI: 10.1136/jmg.25.11.762

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  21 in total

1.  Delineation of specific beta-thalassemia mutations in high-risk areas of Italy: a prerequisite for prenatal diagnosis.

Authors:  M Pirastu; G Saglio; C Camaschella; A Loi; A Serra; T Bertero; W Gabutti; A Cao
Journal:  Blood       Date:  1988-04       Impact factor: 22.113

2.  The molecular basis for the clinical diversity of beta thalassaemia in Cypriots.

Authors:  J S Wainscoat; J M Old; D J Weatherall; S H Orkin
Journal:  Lancet       Date:  1983-06-04       Impact factor: 79.321

3.  DNA analysis in the diagnosis of hemoglobin disorders.

Authors:  M Goossens; Y Y Kan
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

4.  Linkage of beta-thalassaemia mutations and beta-globin gene polymorphisms with DNA polymorphisms in human beta-globin gene cluster.

Authors:  S H Orkin; H H Kazazian; S E Antonarakis; S C Goff; C D Boehm; J P Sexton; P G Waber; P J Giardina
Journal:  Nature       Date:  1982-04-15       Impact factor: 49.962

5.  Prenatal diagnosis of beta-thalassemia. Detection of a single nucleotide mutation in DNA.

Authors:  M Pirastu; Y W Kan; A Cao; B J Conner; R L Teplitz; R B Wallace
Journal:  N Engl J Med       Date:  1983-08-04       Impact factor: 91.245

6.  beta-Thalassemia in Chinese: use of in vivo RNA analysis and oligonucleotide hybridization in systematic characterization of molecular defects.

Authors:  T C Cheng; S H Orkin; S E Antonarakis; M J Potter; J P Sexton; A F Markham; P J Giardina; A Li; H H Kazazian
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

7.  Beta + thalassemia--Portuguese type: clinical, haematological and molecular studies of a newly defined form of beta thalassaemia.

Authors:  G P Tamagnini; M C Lopes; M E Castanheira; J S Wainscoat; W G Wood
Journal:  Br J Haematol       Date:  1983-06       Impact factor: 6.998

8.  A beta-thalassemia lesion abolishes the same Mst II site as the sickle mutation.

Authors:  J C Chang; A Alberti; Y W Kan
Journal:  Nucleic Acids Res       Date:  1983-11-25       Impact factor: 16.971

9.  Base substitution in an intervening sequence of a beta+-thalassemic human globin gene.

Authors:  R A Spritz; P Jagadeeswaran; P V Choudary; P A Biro; J T Elder; J K deRiel; J L Manley; M L Gefter; B G Forget; S M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

10.  Molecular characterization of seven beta-thalassemia mutations in Asian Indians.

Authors:  H H Kazazian; S H Orkin; S E Antonarakis; J P Sexton; C D Boehm; S C Goff; P G Waber
Journal:  EMBO J       Date:  1984-03       Impact factor: 11.598

View more
  1 in total

Review 1.  Why are some genetic diseases common? Distinguishing selection from other processes by molecular analysis of globin gene variants.

Authors:  J Flint; R M Harding; J B Clegg; A J Boyce
Journal:  Hum Genet       Date:  1993-03       Impact factor: 4.132

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.